Research map: Oncological Outcomes and Prognostic Factors of Platinum‐Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum‐Based Chemotherapy Alone: A Propensity Score–Matched Analysis in a Real‐World Population

Back to the article

Papers in this map

  1. Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer · Thomas B. Powles · 2024 · 1079 citations · Cited by this paper
  2. Defining Time Zero and the Comparator in a Real‐World Study of Avelumab Maintenance Therapy · Ruonan Qu · 2026 · Cites this paper
  3. Comprehensive Genomic Characterization Between Urothelial Carcinoma Subtypes/Divergent Differentiation (S/ DD ) and Pure Urothelial Carcinoma Using a Large‐Scale Japanese Genomic Panel Dataset · 2026 · Related
  4. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines · Antoine G. van der Heijden · 2025 · 219 citations · Cited by this paper
  5. Cancer‐Associated Fibroblasts Promote Development of Papillary Renal Cell Carcinoma by Inducing Histone Lactylation of RBM15B to Modify in an m6A ‐Dependent Manner on ANLN · 2026 · Related
  6. A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors · Ali Raza Khaki · 2021 · 63 citations · Cited by this paper
  7. Long‐Term Oncologic Outcomes After Laparoscopic Radical Nephroureterectomy: A Contemporary Analysis From a Japanese Multicenter Cohort · 2026 · Related
  8. Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience · Dimitra Rafailia Bakaloudi · 2023 · 30 citations · Cited by this paper
  9. Diabetes Is an Independent Risk Factor for Radiation‐Induced Hematuria After Robotic Stereotactic Body Radiotherapy for Prostate Cancer · 2026 · Related
  10. J‐AVENUE: A retrospective, real‐world study evaluating patient characteristics and outcomes in patients with advanced urothelial carcinoma treated with avelumab first‐line maintenance therapy in Japan · Eiji Kikuchi · 2024 · 26 citations · Cited by this paper
  11. Artificial Intelligence–Based Objective Evaluation of Nerve‐Sparing Status Combined With Preserved Urethral Length Predicts Urinary Continence Recovery After Robot‐Assisted Radical Prostatectomy · 2026 · Related
  12. Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study · Petros D. Grivas · 2024 · 19 citations · Cited by this paper
  13. Real‐World Outcomes of Radium‐223 Therapy in Metastatic Castration‐Resistant Prostate Cancer: Predictive Value of PSA Doubling Time and Enzalutamide Continuation · 2026 · Related
  14. Avelumab first-line maintenance plus best supportive care (BSC) vs. BSC alone for advanced urothelial carcinoma: JAVELIN Bladder 100 Asian subgroup analysis · Jae‐Lyun Lee · 2023 · 11 citations · Cited by this paper
  15. Efficacy of Testosterone Replacement Therapy Combined With Exercise on Body Composition in Hypogonadal Men · 2026 · Related
  16. Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial · Matthew D. Galsky · 2025 · 10 citations · Cited by this paper
  17. Real‐World Occurrence of Adverse Events Associated With Adjuvant Pembrolizumab Therapy for Renal Cell Carcinoma: A Multicenter Retrospective Study · 2026 · Related
  18. Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Outcomes from the JAVELIN Bladder 100 Trial in Patients with Nonvisceral or Lymph Node–only Disease · Joaquim Bellmunt · 2025 · 8 citations · Cited by this paper
  19. Interpreting Sealing‐Device Effects in Retroperitoneal Laparoscopic Adrenalectomy · 2026 · Related
  20. Real-world effectiveness and treatment (tx) patterns in patients (pts) with locally advanced/metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in Japan: Results from the JAVEMACS chart review study. · Hiroshi Kitamura · 2025 · 5 citations · Cited by this paper
  21. Impact of Absolute PSA Value and Relative PSA Response Rate on Overall Survival in Patients With Metastatic Castration‐Sensitive Prostate Cancer Treated With Androgen Receptor Signaling Inhibitors · 2026 · Related
  22. The first real-world evidence on dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin followed by switch maintenance avelumab in advanced urothelial carcinoma: a propensity score-matched study · Satoru Taguchi · 2025 · 3 citations · Cited by this paper
  23. Avelumab maintenance in advanced urothelial carcinoma: real-world data from Northern Spain (AVEBLADDER study) · Marta Sotelo · 2025 · 3 citations · Cited by this paper
  24. Clinical outcomes and treatment patterns of maintenance avelumab in locally advanced or metastatic urothelial carcinoma: a multicenter collaborative study · Yuki Taneda · 2025 · 2 citations · Cited by this paper
  25. Untitled · Cited by this paper
  26. Untitled · Cited by this paper
  27. Untitled · Cited by this paper
  28. Untitled · Cited by this paper
  29. Untitled · Cited by this paper

Source: OpenAlex (CC0)